Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 4/20 | 0.39 |
| ▸ | NOS3 | P29474 | 3/20 | 0.39 |
| ▸ | CCR1 | P32246 | 1/20 | 0.35 |
| ▸ | CCR5 | P51681 | 1/20 | 0.35 |
| ▸ | CCR8 | P51685 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26267058 | 0.71 | NOS2 (0.39) | NOS2NOS3CCR1CCR5CCR8 | |
| SCHEMBL26267082 | 0.69 | NOS3 (0.34) | NOS2NOS3CCR1CCR5CCR8 | |
| SCHEMBL26266978 | 0.69 | NOS3 (0.42) | NOS2NOS3CCR1CCR5CCR8 | |
| SCHEMBL1869137 | 0.69 | METAP2 (0.40) | NOS2NOS3 | |
| SCHEMBL26267063 | 0.68 | NOS3 (0.37) | NOS2NOS3CCR1CCR5CCR8 | |
| SCHEMBL26266981 | 0.68 | NOS3 (0.37) | NOS2NOS3CCR1CCR5CCR8 | |
| SCHEMBL30613656 | 0.68 | TDP2 (0.37) | NOS2NOS3CCR1CCR5CCR8 | |
| SCHEMBL26135340 | 0.68 | TDP2 (0.37) | NOS2NOS3CCR1CCR5CCR8 | |
| SCHEMBL26266985 | 0.68 | NOS3 (0.37) | NOS2NOS3CCR1CCR5CCR8 | |
| SCHEMBL26266749 | 0.68 | NOS3 (0.37) | NOS2NOS3CCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018037-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12018037-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | ORC3, LEF1, OCIAD1 | NOS2 2103/4885NOS3 2171/4885CCR1 2833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.